Revenue Summary of Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation's latest annual revenue in 2023 was 382.05 Million TWD , down -7.21% from previous year.
Abnova (Taiwan) Corporation's latest quarterly revenue in 2024 Q1 was 85 Million TWD , down -9.55% from previous quarter.
Abnova (Taiwan) Corporation reported a annual revenue of 411.75 Million TWD in annual revenue 2022, down -8.8% from previous year.
Abnova (Taiwan) Corporation reported a annual revenue of 451.48 Million TWD in annual revenue 2021, down -1.09% from previous year.
Abnova (Taiwan) Corporation reported a quarterly revenue of 85 Million TWD for 2024 Q1, down -9.55% from previous quarter.
Abnova (Taiwan) Corporation reported a quarterly revenue of 93.89 Million TWD for 2023 Q3, down -4.92% from previous quarter.

Annual Revenue Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Revenue of Abnova (Taiwan) Corporation (2023 - 2009)

Year	Revenue	Revenue Growth
2023	382.05 Million TWD	-7.21%
2022	411.75 Million TWD	-8.8%
2021	451.48 Million TWD	-1.09%
2020	456.44 Million TWD	10.21%
2019	414.15 Million TWD	-2.79%
2018	426.02 Million TWD	-10.32%
2017	475.07 Million TWD	8.01%
2016	439.82 Million TWD	-2.56%
2015	451.36 Million TWD	3.03%
2014	438.11 Million TWD	-5.52%
2013	463.69 Million TWD	-0.02%
2012	463.77 Million TWD	-1.86%
2011	472.56 Million TWD	-0.53%
2010	475.07 Million TWD	17.93%
2009	402.83 Million TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	91.77 Million TWD	7.97%
2024 Q1	85 Million TWD	-9.55%
2023 Q3	93.89 Million TWD	-4.92%
2023 Q1	95.42 Million TWD	-11.63%
2023 FY	382.05 Million TWD	-7.21%
2023 Q2	98.75 Million TWD	3.49%
2023 Q4	93.97 Million TWD	0.08%
2022 FY	411.75 Million TWD	-8.8%
2022 Q2	102.94 Million TWD	3.74%
2022 Q3	101.6 Million TWD	-1.3%
2022 Q4	107.97 Million TWD	6.28%
2022 Q1	99.23 Million TWD	2.43%
2021 Q2	124.25 Million TWD	8.68%
2021 Q1	114.32 Million TWD	-4.31%
2021 Q4	96.88 Million TWD	-16.5%
2021 FY	451.48 Million TWD	-1.09%
2021 Q3	116.02 Million TWD	-6.62%
2020 Q3	133.74 Million TWD	29.44%
2020 FY	456.44 Million TWD	10.21%
2020 Q1	99.91 Million TWD	-3.31%
2020 Q2	103.31 Million TWD	3.41%
2020 Q4	119.48 Million TWD	-10.66%
2019 Q3	98.66 Million TWD	-4.76%
2019 FY	414.15 Million TWD	-2.79%
2019 Q1	108.58 Million TWD	12.81%
2019 Q4	103.32 Million TWD	4.73%
2019 Q2	103.59 Million TWD	-4.6%
2018 Q3	106.15 Million TWD	-7.08%
2018 Q2	114.24 Million TWD	4.46%
2018 FY	426.02 Million TWD	-10.32%
2018 Q4	96.25 Million TWD	-9.33%
2018 Q1	109.37 Million TWD	-1.89%
2017 Q2	122.34 Million TWD	2.25%
2017 Q4	111.48 Million TWD	-8.31%
2017 Q1	119.65 Million TWD	15.79%
2017 FY	475.07 Million TWD	8.01%
2017 Q3	121.58 Million TWD	-0.62%
2016 Q2	111.51 Million TWD	-5.34%
2016 FY	439.82 Million TWD	-2.56%
2016 Q4	103.34 Million TWD	-3.56%
2016 Q3	107.15 Million TWD	-3.91%
2016 Q1	117.8 Million TWD	4.94%
2015 FY	451.36 Million TWD	3.03%
2015 Q4	112.26 Million TWD	7.25%
2015 Q2	123.18 Million TWD	10.75%
2015 Q3	104.67 Million TWD	-15.03%
2015 Q1	111.23 Million TWD	0.78%
2014 Q3	108.63 Million TWD	-1.57%
2014 FY	438.11 Million TWD	-5.52%
2014 Q4	110.37 Million TWD	1.6%
2014 Q2	110.37 Million TWD	1.51%
2014 Q1	108.72 Million TWD	1.81%
2013 Q3	110.97 Million TWD	-4.5%
2013 Q4	106.79 Million TWD	-3.77%
2013 FY	463.69 Million TWD	-0.02%
2013 Q1	129.72 Million TWD	10.62%
2013 Q2	116.2 Million TWD	-10.42%
2012 Q3	115.67 Million TWD	4.63%
2012 FY	463.77 Million TWD	-1.86%
2012 Q4	117.26 Million TWD	1.38%
2012 Q2	110.55 Million TWD	-8.08%
2012 Q1	120.27 Million TWD	0.36%
2011 Q3	112.55 Million TWD	-4.12%
2011 Q4	119.84 Million TWD	6.48%
2011 FY	472.56 Million TWD	-0.53%
2011 Q1	122.78 Million TWD	8.72%
2011 Q2	117.38 Million TWD	-4.4%
2010 Q1	114.92 Million TWD	0.0%
2010 FY	475.07 Million TWD	17.93%
2010 Q3	120.81 Million TWD	-4.41%
2010 Q4	112.94 Million TWD	-6.52%
2010 Q2	126.39 Million TWD	9.98%
2009 FY	402.83 Million TWD	0.0%

Peer Revenue Comparison of Abnova (Taiwan) Corporation

Name	Revenue	Revenue Difference
Apex Biotechnology Corp.	1.67 Billion TWD	77.212%
Sinphar Pharmaceutical Co.,Ltd.	2.96 Billion TWD	87.106%
Panion & Bf Biotech Inc.	1.88 Billion TWD	79.698%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	2.08 Billion TWD	81.689%
GenMont Biotech Incorporation	318.01 Million TWD	-20.136%
Adimmune Corporation	1.78 Billion TWD	78.598%
Tanvex BioPharma, Inc.	61.41 Million TWD	-522.123%
Polaris Group	7.48 Million TWD	-5006.964%
Energenesis Biomedical CO.,LTD.	7.15 Million TWD	-5237.413%
UnicoCell Biomed Co., Ltd.	24.58 Million TWD	-1453.752%
PELL Bio-Med Technology Co. Ltd.	18.03 Million TWD	-2018.627%

Global Stocks Search

Abnova (Taiwan) Corporation (4133.TW)

Revenue Summary of Abnova (Taiwan) Corporation

Annual Revenue Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Revenue of Abnova (Taiwan) Corporation (2023 - 2009)

Peer Revenue Comparison of Abnova (Taiwan) Corporation